Perceptive Advisors’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $30.9M | Buy |
|
|||||
|
2025
Q2 | $15.9M | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $10.4M | Sell |
|
|||||
|
2021
Q1 | $16.6M | Sell |
|
|||||
|
2020
Q4 | $16.9M | Hold |
|
|||||
|
2020
Q3 | $17.1M | Hold |
|
|||||
|
2020
Q2 | $21.5M | Sell |
|
|||||
|
2020
Q1 | $25M | Hold |
|
|||||
|
2019
Q4 | $27M | Hold |
|
|||||
|
2019
Q3 | $24M | Buy |
|
|||||
|
2019
Q2 | $35.4M | Sell |
|
|||||
|
2019
Q1 | $34.1M | Buy |
|
|||||
|
2018
Q4 | $43.6M | Buy |
|
|||||
|
2018
Q3 | $49.2M | Buy |
|
|||||
|
2018
Q2 | $43.9M | Sell |
|
|||||
|
2018
Q1 | $62.8M | Sell |
|
|||||
|
2017
Q4 | $52.6M | Buy |
|
|||||
|
2017
Q3 | $25.3M | Hold |
|
|||||
|
2017
Q2 | $21.6M | Sell |
|
|||||
|
2017
Q1 | $26.4M | Buy |
|
|||||
|
2016
Q4 | $10.2M | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $7.58M | Hold |
|
|||||
|
2016
Q1 | $9.57M | Buy |
|
|||||
|
2015
Q4 | $13.4M | Buy |
|